Capital Adept
  • Politics
  • Investing
  • Stocks
  • Business
  • Politics
  • Investing
  • Stocks
  • Business

Capital Adept

Business

UnitedHealth CEO suddenly steps down for ‘personal reasons’

by admin May 14, 2025
May 14, 2025
UnitedHealth CEO suddenly steps down for ‘personal reasons’

UnitedHealth Group announced a new chief executive Tuesday, a sudden and surprising change following the fatal shooting in December of its UnitedHealthcare subsidiary’s leader.

Andrew Witty stepped down from leading UnitedHealth for unspecified “personal reasons,” the company said. Stephen J. Hemsley, who served as chief executive from 2006 to 2017, will return to the role and remain board chairman. Witty will serve as a senior adviser to Hemsley, the company said in a news release. 

UnitedHealth has been the focus of sharp criticism over the health insurance industry’s practices and has seen its stock plummet in the past year. The Justice Department has investigated its business activities.

UnitedHealth’s shares fell more than 17% Tuesday. The stock, which is part of the 30-company Dow Jones Industrial Average, closed at $311.38 a share, well off its recent high of $630.73 in November.

The company also said that it has suspended its annual outlook for 2025, to include ‘more types of benefit offerings than seen in the first quarter’ and because ‘the medical costs of many Medicare Advantage beneficiaries new to UnitedHealthcare remained higher than expected.’

‘The company expects to return to growth in 2026,’ the statement added.

In December, United Healthcare CEO Brian Thompson was fatally shot in what police described as a “premeditated, preplanned targeted attack” in midtown Manhattan as he was walking to an investors’ conference. 

Luigi Mangione, now 27, was arrested after a five-day manhunt at a McDonald’s in Altoona, Pennsylvania.

He faces federal and state charges in New York and Pennsylvania in connection with the shooting. He has pleaded not guilty to the murder and terrorism charges in New York, and not guilty to federal stalking and murder charges. If convicted of federal charges, Mangione could be sentenced to death.



This post appeared first on NBC NEWS

previous post
Navigating Earnings: Three Stocks, Three Different Stories
next post
Father and son fraudsters sentenced in case of $100 million New Jersey deli

Related Posts

Nike pushes back Skims launch with Kim Kardashian...

June 20, 2025

PepsiCo buys prebiotic soda brand Poppi for nearly...

March 18, 2025

Meta’s head of AI research announces departure

April 2, 2025

American Eagle shares plunge 17% after it withdraws...

May 15, 2025

A top Federal Reserve official says bleak jobs...

August 12, 2025

Harvard’s battle with the Trump administration is creating...

April 19, 2025

UnitedHealthcare sued by shareholders over reaction to CEO’s...

May 9, 2025

How new professional sports leagues like SailGP are...

March 21, 2025

Elon Musk confirms Tesla has signed a $16.5...

July 29, 2025

Murdoch to provide Trump health updates in deal...

August 6, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Copper Price Update: Q1 2025 in Review

      April 14, 2025
    • 2

      The Best Five Sectors, #10

      March 14, 2025
    • 3

      DP Trading Room: Market Sell-Off

      March 14, 2025
    • 4

      5 Strong Stocks Defying the Bearish Market!

      March 14, 2025
    • 5

      Sector Rotation Warning: More Downside Ahead for US Markets?

      March 14, 2025
    • 6

      Transform Your Investing Strategy: Uncover the 3 Game-Changing Rules

      March 14, 2025
    • 7

      Did Friday’s Reversal Mark A Major Bottom?

      March 14, 2025
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 capitaladept.com | All Rights Reserved